Physician
Obstetrics & Gynecology
Dr. Parviz Hanjani, MD
|
|
Give Review
Doctor Parviz Hanjani, MD is an expert in the field of Obstetrics & Gynecology. He studied medicine at SUNY Upstate Medical University. He received awards:"Fellow (FACOG)". Parviz Hanjani is a published doctor and has 66 publications published. The lastest was: 'Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: An NRG Oncology/Gynecologic On...
- A parallel-arm phase I trial of the Humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the ...
- A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study.
- Temsirolimus with or without megestrol acetate and tamoxifen for endometrial Cancer: A gynecologic oncology group study.
- A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial Cancer: A Gynecologic Oncology Group study.
- A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal Carcinomas: A Gynecologic Oncol...
- Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial Carcinoma: a Gynecologic Oncology Group study.
- Phase II evaluation of 3-day topotecan with cyclophosphamide in the treatment of recurrent ovarian Cancer.
- Peritoneal cytology of uncommon Ovarian tumors.
- Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell Carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
- Telephone counseling improves adherence to colposcopy among lower-income minority women.
- Adverse psychologic consequences of positive cytologic Cervical screening.
- Mesonephric rest hyperplasia. A potential diagnostic pitfall.
- A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell Carcinoma of the cervix. A Gynecologic Oncology Group study.
- Phase II trial of vinblastine in advanced ovarian Carcinoma. A Gynecologic Oncology Group study.
- Intraepithelial neoplasia of the lower genital tract.
- Aminothiadiazole (NSC 4728) in patients with advanced Carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group.
- A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell Carcinoma of the cervix: a Gynecologic Oncology Group Study.
- Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent Carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.
- Detection of Human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
- Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian Carcinoma ascitic fluid.
- Psammoma bodies in neuroendocrine Carcinoma of the uterine cervix.
- Biopsy of the scalene fat pad in Carcinoma of the cervix uteri metastatic to the periaortic lymph nodes.
- EndoCervical curettage: does it contribute to the management of patients with abnormal Cervical cytology?
- Secretion of a 97 kilodalton glycoprotein by primary cultures of Human ovarian epithelial tumor cells.
- EndoCervical neoplasia in long-term users of oral contraceptives: clinical and pathologic observations.
- Sclerosing stromal tumor and bilateral teratomas: an unusual association.
- Association of a 97 kilodalton glycoprotein with human ovarian Carcinoma.
- Treatment of advanced and recurrent squamous cell Carcinoma of the cervix with combination doxorubicin and cyclophosphamide.
- Malignant mixed Mullerian tumor of the Fallopian tube. Report of a case and review of literature.
- Synthesis of catechol estrogens by Human uterus and leiomyoma.
- Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: report of eight cases and review of literature.
- Extragenital malignant mixed Müllerian tumor. Case report and review of the literature.
- Extended field irradiation for Cervical cancer based on surgical staging.
- Adjuvant therapy of Ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.
- A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell Carcinoma of the cervix. A Gynecologic Oncology Group Study.
- Phase II trial of intraperitoneal paclitaxel in Carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study.
- Intraperitoneal alpha-interferon alternating with cisplatin in residual ovarian Carcinoma: a phase II Gynecologic Oncology Group study.
- Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian Cancer: A Gynecologic Oncology Group study.
- Topotecan in squamous cell Carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
- Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian Cancer.
- BRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian Cancer cases: a Gynecologic Oncology Group study.
- Uterine papillary serous Carcinoma after pelvic radiation therapy for cancer of the cervix.
- To peritonealise or not to peritonealise? A randomised trial at abdominal hysterectomy in Iran.
- Simple hysterectomy in the presence of invasive Cervical cancer in Iran.
- Borderline Ovarian tumours: clinical analysis of 38 cases.
- EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II-IV).
- Successful treatment of two patients with gestational trophoblastic neoplasm presenting with emergent neurologic symptoms.
- Evaluation and management of brain metastatic patients with high-risk gestational trophoblastic tumors.
- Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
- Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia.
- Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal Cancers: a Gynecologic Oncology Group study.
- Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal Cancer: a phase II study of the Gynecologic Oncology Group.
- Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia.
- Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian Cancers: a Gyne...
- Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal Carcinoma: a study of the Gynecologic On...
- Evaluation of two management strategies for preoperative grade I endometrial Cancer.
- Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
- Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal Cancer after up to three prior regimens: a phase II study of the Gy...
- A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic valu...
- A randomized phase III trial of IV carboplatin and paclitaxel à 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-...
- Phase II trial of bevacizumab in recurrent or persistent endometrial Cancer: a Gynecologic Oncology Group study.
- Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial Ovarian malignancy: a gynecologi...
- Management of patients with metastatic gestational trophoblastic tumor.
- Embryonal rhabdomyosarcoma of the Uterine cervix: case report and review of the literature.
Schools
Teheran University Faculty of Medicine
Cook Co Hospital
SUNY Kings Co Hospital
Upstate Med Center
Roswell Park Meml Hospital
University Tenn
Procedures Preformed
- Colposcopy
- Gynecologic Cancer Screening
- Hysterectomy - Open
- Lymph Node Biopsy or Excision
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Endometriosis
- Fallopian Tube Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health America PPO
- Coventry Health Care of Delaware PPO
- GHI PPO
- First Health (Coventry Health Care) PPO
- HealthPartners
- Community Blue PPO
- Choice Care PPO
- Keystone Health Plan East HMO
- Medicare MCR
- MultiPlan PPO
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- Fellow (FACOG)
Education
-
University of Tennessee -
SUNY Upstate Medical University -
SUNY Health Science Center at Brooklyn -
John H. Stroger Hospital of Cook County
Hospital
-
Abington Hospital - Jefferson Health
Drug Facts
| NPI NUMBER | 1750369864 | |
| NPPES Provider LastName | HANJANI | |
| NPPES Provider FirstName | PARVIZ | |
| NPPES Provider ZIPCode | 190013720 | |
| NPPES Provider State | PA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 40.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750369864 |
| Last Name Of The Provider | HANJANI |
| First Name Of The Provider | PARVIZ |
| View All |
Similar Doctors
|
|
Dr. Amelia S. McLennan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen T. Feisullin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Elizabeth R. Burton, MD |
|
Dr. Philip G. Sih, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell I. Edelson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark S. Shahin, MD
This Doctor is OpenDoctor Recommended.
|